RESEARCH TRIANGLE PARK, N.C. – January 19, 2010 – Quintiles today announced that Paula Brown Stafford, Executive Vice President, Integrated Clinical Services, has been elected chair-elect of the Board of Directors of CDISC, a global organization that leads the development of standards to reduce complexity in biomedical research to speed new therapies to market and improve the flow of research information to healthcare.
CDISC, the Clinical Data Interchange Standards Consortium, is an open, multidisciplinary non-profit organization that has established worldwide industry standards to support the electronic acquisition, exchange, submission and archiving of clinical study data. The mission of CDISC is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. The CDISC Board sets strategic direction for the organization.
CDISC is assisting the industry in eliminating complexity as biopharmaceutical companies strive to be more efficient and productive in drug development,” Stafford said. “The biopharmaceutical industry is trying to manage constantly evolving data standards. I am very pleased to assume this new role on the CDISC Board, working with a very strong team of experts in our efforts to speed new medicines to market and increase their value to patients.”
Rebecca Kush, Ph.D., CDISC President and CEO, said: “Paula has been a significant contributor to the CDISC Board since joining in 2006, helping us expand our horizons to support clinical research in an environment of constantly evolving data standards. We are very glad she has agreed to accept more responsibility as we continue to work toward harmonization of research data standards with healthcare standards and the advancement of Electronic Health Records and Health Information Technology to support research as well as clinical care.”
Stafford joined Quintiles in 1985 as a biostatistician and has held a number of positions of increasing responsibility within the company, including leadership roles in data management, project management in the U.S. and in Europe, business development, scientific operations and general management.
She is a member of the Board of Directors of Cenduit, an Interactive Response Technology company, the Public Health Foundation Board of Directors at the UNC Gillings School of Global Public Health and the External Advisory Board at The North Carolina Translational and Clinical Sciences Institute.
Quintiles is a founding member of CDISC. Gary Walker, Associate Director, Clinical Data Management for Quintiles, was recently elected CDISC Advisory Board representative to the CDISC Board of Directors Technical Advisory Committee (TAC). The TAC provides research and advice to the Board on technical issues.
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of 23,000 engaged professionals in more than 50 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.